News & Events | Alkemist Bio

top of page

News

ALKemist Bio announces Sponsored Research Agreement with Boston Children’s Hospital and secures Exclusive License for Groundbreaking Cancer Therapy - July 2nd , 2024

Newly launched TCR company ALKemist Bio announces a €6.9M Investment Round to develop first-in-class TCR Cell Therapy for ALK-Positive Tumors - December 21st, 2023

ALKemist Bio appoints Adi Hoess to Board of Directors - December 17th, 2024

bottom of page